Balance Sheet
Accounts PayablesAssetsCapital LeasesCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Actinium Pharmaceuticals (ATNM) Accumulated Depreciation (2023)

Actinium Pharmaceuticals (ATNM) has disclosed Accumulated Depreciation for 1 consecutive years, with $694000.0 as the latest value for Q4 2023.

  • Quarterly Accumulated Depreciation changed N/A to $694000.0 in Q4 2023 from the year-ago period, while the trailing twelve-month figure was $694000.0 through Dec 2023, changed N/A year-over-year, with the annual reading at $694000.0 for FY2023, N/A changed from the prior year.
  • Accumulated Depreciation for Q4 2023 was $694000.0 at Actinium Pharmaceuticals.
  • The five-year high for Accumulated Depreciation was $694000.0 in Q4 2023, with the low at $694000.0 in Q4 2023.